BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17608773)

  • 1. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H; Karube K; Tsuzuki S; Ohshima K; Seto M
    Cancer Sci; 2007 Sep; 98(9):1482-90. PubMed ID: 17608773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-17-92 cluster microRNAs confers tumorigenicity in multiple myeloma.
    Chen L; Li C; Zhang R; Gao X; Qu X; Zhao M; Qiao C; Xu J; Li J
    Cancer Lett; 2011 Oct; 309(1):62-70. PubMed ID: 21664042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
    Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
    Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC translocation-negative classical Burkitt lymphoma cases: an alternative pathogenetic mechanism involving miRNA deregulation.
    Leucci E; Cocco M; Onnis A; De Falco G; van Cleef P; Bellan C; van Rijk A; Nyagol J; Byakika B; Lazzi S; Tosi P; van Krieken H; Leoncini L
    J Pathol; 2008 Dec; 216(4):440-50. PubMed ID: 18802929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
    Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
    Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homogeneous immunophenotype and paucity of secondary genomic aberrations are distinctive features of endemic but not of sporadic Burkitt's lymphoma and diffuse large B-cell lymphoma with MYC rearrangement.
    Barth TF; Müller S; Pawlita M; Siebert R; Rother JU; Mechtersheimer G; Kitinya J; Bentz M; Möller P
    J Pathol; 2004 Aug; 203(4):940-5. PubMed ID: 15258997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
    Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
    Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma.
    Ota A; Tagawa H; Karnan S; Tsuzuki S; Karpas A; Kira S; Yoshida Y; Seto M
    Cancer Res; 2004 May; 64(9):3087-95. PubMed ID: 15126345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC and aggressive B-cell lymphomas.
    Slack GW; Gascoyne RD
    Adv Anat Pathol; 2011 May; 18(3):219-28. PubMed ID: 21490439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of p21 by c-Myc through members of miR-17 family at the post-transcriptional level.
    Wang Z; Liu M; Zhu H; Zhang W; He S; Hu C; Quan L; Bai J; Xu N
    Int J Oncol; 2010 Nov; 37(5):1315-21. PubMed ID: 20878079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas.
    Kluiver J; Poppema S; de Jong D; Blokzijl T; Harms G; Jacobs S; Kroesen BJ; van den Berg A
    J Pathol; 2005 Oct; 207(2):243-9. PubMed ID: 16041695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semi-quantitative fluorescence in situ hybridization analysis indicates that the myc protein is consistently stabilized both before and after transformation of low-grade follicular center to high-grade diffuse large cell lymphoma.
    Albalwi M; Hammond DW; Goepel JR; Hough RE; Goyns MH
    Lab Invest; 1999 Jun; 79(6):707-15. PubMed ID: 10378513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apoptosis induction by antisense oligonucleotides against miR-17-5p and miR-20a in lung cancers overexpressing miR-17-92.
    Matsubara H; Takeuchi T; Nishikawa E; Yanagisawa K; Hayashita Y; Ebi H; Yamada H; Suzuki M; Nagino M; Nimura Y; Osada H; Takahashi T
    Oncogene; 2007 Sep; 26(41):6099-105. PubMed ID: 17384677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma.
    Kluiver J; van den Berg A; de Jong D; Blokzijl T; Harms G; Bouwman E; Jacobs S; Poppema S; Kroesen BJ
    Oncogene; 2007 May; 26(26):3769-76. PubMed ID: 17173072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer.
    Hu X; Macdonald DM; Huettner PC; Feng Z; El Naqa IM; Schwarz JK; Mutch DG; Grigsby PW; Powell SN; Wang X
    Gynecol Oncol; 2009 Sep; 114(3):457-64. PubMed ID: 19501389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
    Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
    Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of B- and T-lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles.
    Fulci V; Colombo T; Chiaretti S; Messina M; Citarella F; Tavolaro S; Guarini A; Foà R; Macino G
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1069-82. PubMed ID: 19760605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-429 modulates the expression of c-myc in human gastric carcinoma cells.
    Sun T; Wang C; Xing J; Wu D
    Eur J Cancer; 2011 Nov; 47(17):2552-9. PubMed ID: 21684154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
    Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
    Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.